Original air date 8.24.21. Drug repositioning traditionally deploys new formulations or methods of treatment to protect the repositioned intellectual property estate. However, there are circumstances where it is possible to get an additional composition of matter patent for the repositioned asset, namely, by using a solid form patent strategy. This article discusses the theory and practice behind using solid form patents to start a new composition of matter clock and how this strategy has been deployed in practice.
Presented by: Eyal Barash of Barash Law LLC
For information on CLE accreditation, please contact our CLE Department at firstname.lastname@example.org. CLE credit may be available, but will require additional time for approval and COA delivery.